*6816* 6816 CONSENT FOR DECEASED KIDNEY DONOR ORGAN OPTIONS



Similar documents
Where Will my New Kidney Come From?

Questions and Answers for Transplant Candidates about the New Kidney Allocation System

Saint Francis Kidney Transplant Program Issue Date: 6/9/15

THE BENEFITS OF LIVING DONOR KIDNEY TRANSPLANTATION. feel better knowing

Organ and Tissue Donation: An Overview

Candidates about Multiple Listing and Waiting Time Transfer

Donating Life. The Workplace Partnership for Life Program

Kidneys. Kidney Failure4. Transplantation

The New Kidney Allocation System: Resources for Protocols and Processes webinar.

How does a kidney transplant differ from dialysis?

Heart transplantation

Living Donor Paired Exchange Registry. What is Living Kidney Donor Paired Exchange?

Kidney Transplantation

Kidney Disease WHAT IS KIDNEY DISEASE? TESTS TO DETECT OR DIAGNOSE KIDNEY DISEASE TREATMENT STRATEGIES FOR KIDNEY DISEASE

Deceased Organ Donor Potential in Canada

AN ADVANCE CARE DIRECTIVE A GIFT OF PREPAREDNESS

TA L K I N G A B O U T T R A N S P L A N TAT I O N

Transplant Coordinator

What is a Living Will?

LIVING KIDNEY DONATION

NOTICE TO THE INDIVIDUAL SIGNING THE ILLINOIS POWER OF ATTORNEY FOR HEALTH CARE

LIFE CARE planning. Advance Health Care Directive. my values, my choices, my care WASHINGTON. kp.org/lifecareplan

Is a kidney transplant right for me?

David Axelrod, MD, MBA. Associate Professor of Surgery Section Chief- Solid Organ Transplantation Dartmouth- Hitchcock Medical Center

Is a Kidney Transplant Right for Me?

Advance Health Care Planning: Making Your Wishes Known

TEXAS MEDICAL POWER OF ATTORNEY

Learning about Hepatitis C and Chronic Kidney Disease

4/25/2016. Transplant Journey. Objectives. Reason for Transplantation at Mayo Clinic. Mayo Clinic Model of Care

May Introduction

GEORGIA ADV ANCE DIRECTIV E FOR HEALTH

Overview of Organ Donation and Transplantation

State of Ohio Living Will Declaration Notice to Declarant

Kidney Transplant Program. Guide to Understanding Transplant

Body, Brain and Tissue Donation Pack

Organ Donation Qatar. A gift that lasts a lifetime.

Simplified Advance Care Plan and Living Will (Optional)

Booklet B The Menace of Alcohol

GEORGIA ADVANCE DIRECTIVE FOR HEALTH CARE

Where World-Class Expertise and Genuine Compassion Come Together. AT THE FOREFRONT OF TRANSPLANT CARE Kidney Combined Kidney-Pancreas Pancreas Islets

Blood Transfusion. There are three types of blood cells: Red blood cells. White blood cells. Platelets.

Demystifying Transplant Performance Reviews. Robyn Zernhelt Performance Analyst

Why and how to have end-of-life discussions with your patients:

ADVANCE DIRECTIVE. Your Right to Make Health Care Decisions

DIABETES. Eyes, Heart, Nerves, Feet, and Kidneys.

LIVING DONATION. What You Need to Know.

Cardio-Pulmonary Resuscitation (CPR): A Decision Aid For. KGH Patients And Their Families

It s not something you want to think about, but it s something you want to prepare for.

CONSENT FORM. Procedure: Descemet s Stripping Automated Endothelial Keratoplasty (DSAEK)

& Care & Choices at the End of Life. Advance Directive. Planning for Important Healthcare Decisions

NOTICE TO THE INDIVIDUAL SIGNING THE POWER OF ATTORNEY FOR HEALTH CARE

DPower of Attorney for Health Cared

Lymphomas after organ transplantation

You know them well They know you well You trust them to do what you desire And, you trust them to do what is best for you.

CRACKING GOOD COVER. Protection Personal Menu. royallondon.com

My Voice. Advance Care Plan

USLIFE Group Voluntary Term Life Insurance Coversheet

Information for Patients. Advance Health Care Directive Kit A guide to help you express your health care wishes

DONOR INFORMATION PACKET. Anatomical Board University of Central Florida College of Medicine

Power of Attorney for Health Care For

Red Blood Cell Transfusions for Sickle Cell Disease

INFORMED CONSENT DERMABRASION

DURABLE HEALTH CARE POWER OF ATTORNEY AND HEALTH CARE TREATMENT INSTRUCTIONS (LIVING WILL) PART I INTRODUCTORY REMARKS ON HEALTH CARE DECISION MAKING

UCSF Communicable Disease Surveillance and Vaccination Policy

CORD BLOOD TRANSPLANTATION STUDY EXPANDED ACCESS PROTOCOL APPENDIX A SAMPLE CONSENT FORM

GASTRIC BYPASS SURGERY CONSENT FORM

Premature Infant Care

Quality Scorecard overall heart attack care overall heart failure overall pneumonia care overall surgical infection rate patient safety survival

Viral Hepatitis A, B, and C

PANCREAS, PANCREAS-KIDNEY, SEGMENT OF PANCREAS AND ISLET PANCREATIC TISSUE TRANSPLANTATION SUR

SUGGESTIONS & REQUIREMENTS For Medical Power of Attorney & Completing the Texas Will to Live Form

NATCO Introductory Education Course Objectives

Georgia Advance Directive for Health Care

Arizona Health Care Power of Attorney Living Will Directions for Disposition of Body at Death

OFFICE OF THE ARIZONA ATTORNEY GENERAL Mark Brnovich. STATE OF ARIZONA DURABLE HEALTH CARE POWER OF ATTORNEY Instructions and Form

2 North Meridian Street Indianapolis, Indiana March 1999 Revised May 2004 Revised July 1, 2013 ADVANCE DIRECTIVES YOUR RIGHT TO DECIDE

ARIZONA Advance Directive Planning for Important Health Care Decisions

Management of hepatitis C: pre- and post-liver transplantation. Piyawat Komolmit Bangkok

Information for people who have an increased risk of Creutzfeldt-Jakob disease (CJD)

Introduction. Evaluation

Medical Questionnaire and Informed Consent Public Cord Blood Bank Switzerland

Directive to Physicians and Family Members

BLOOD TRANSFUSION SAFETY

Transcription:

The shortage of kidney donors and the ever-increasing waiting list has prompted the transplant community to look at different types of organ donors to meet the needs of our patients on the waiting list. The purpose of this consent form is to summarize information you have been given about the different types of organ donors and allow you to indicate the type(s) of donor organs you are willing to consider if they become available. The kidney donor profile index (KDPI) combines a variety of donor factors into a single number that summarizes the likelihood of a graft failure after a deceased donor kidney transplant. The KDPI tells you how long a deceased donor kidney is expected to function relative to all of the kidneys recovered in the U.S. during the last year. Lower KDPI scores are associated with longer estimated function, while higher KDPI scores are associated with shorter estimated function. For example, a kidney with a KDPI of 20% is expected to have a longer function than 80% of the recovered kidneys. Historically, there are five general types of kidney donors available: Standard Criteria Donors, Extended Criteria Donors, Donors after Cardiac Death, Hepatitis B Positive Donors, and Donors who are at increased risk for disease transmission. There is a wide variation of expected kidney function within these categories. KDPI wll provide more information on expected kidney function. This form only summarizes the differences between these different types of donor organs and the associated risks and benefits of each type. This consent form specifically addresses the risks associated with the donor organ. A separate consent form addresses the overall risks associated with kidney transplantation. 1. KDPI 0-85% Standard criteria donor organs have been procured from donors who have died due to a fatal brain injury and who are between 1 and 60 years of age. These donors have either none or not more than one of risk factors associated with kidney disorders, such as elevated creatinine (a blood test which reflects kidney function), high blood pressure, diabetes and/or history of stroke or bleeding in or around the brain. These kidneys will correspond now to a kidney with a KDPI of 0 85%. These organs, as a general matter, present lower risk of serious complications after transplant and a higher chance of functioning well and for a longer period of time than non-standard donor organs. However, there is no guarantee that standard criteria donor organs don t have inherent risk factors. You have the right to refuse this standard kidney when it is offered. This refusal will not impact your status on the UNOS transplant wait list. time. I understand the benefits and risks of KDPI 0-85% Donors and I agree to be on the list for this type of kidney transplant. I do not wish to be placed on the wait list for a KDPI 0-85% Donor kidney. 2. KDPI > 85% Donors (formerly Extended Criteria Donors) : due to medical conditions or age Historically these organs were called Extended Criteria Donor Kidney, but now will refer to organs with a KDPI >85%. KDPI means Kidney Donor Profile Index and is a refined measure of kidney quality. It is a grade of the usability of deceased donor kidneys. The KDPI is a continuous score from 1 to 100 with the highest quality kidney having a score of 1 and the lowest quality having a score of 100. A kidney with a KDPI >85% has a higher chance of not working as well or as long as a kidney from a Standard-Criteria Donor or a KDPI between 1 85%.. There is a higher risk of delayed kidney function with KDPI >85% Donor kidneys, which may require the recipient to receive dialysis for a period of time after transplant. About 1-2 % of ECD kidneys may never work well enough after transplantation to allow you to HH Forms 577068 R11-14 Printed by the Digital Print Center @ HH Page 1 of 5

come off dialysis. This is a slightly higher risk than that for a standard criteria donor kidney. There is also a higher chance that the transplanted kidney will not function as well or as long (measured by creatinine levels) as compared to Standard Criteria Donor kidneys, which may result in the recipient needing dialysis or a new transplant over time. These risks may also increase the overall risks of the transplant surgery itself and the risks and side effects of the post-transplant medications. However, most people who have KDPI >85% Donor kidneys will live longer than those on dialysis. Studies have indicated that a transplant from a KDPI >85% Donor may be better than no transplant at all. Patients in such studies who had KDPI >85% Donor kidneys lived longer than those on dialysis who never received a transplant. You will be provided a copy of the Scientific Registry of Transplant Recipients ( SRTR ) annual data report if you request it. KDPI 1 YR Estimated Graft Survival 2 YR Estimated Graft Survival 0-20 Greater than or = to 93.5% Greater than or = to 90.0% 20-85 93-87% 90-80.4% 85100 87-81% 80-72% OPTN/UNOS 2014 Being listed for a KDPI >85% Donor kidney may shorten the wait time for a transplant. Waiting times get longer every year and many patients die waiting for a kidney transplant. A reduced wait time may also increase the chance of receiving a transplant before beginning dialysis. Patients who receive a kidney transplant prior to beginning dialysis in general experience fewer complications associated with their kidney disease and transplant than those who are transplanted after being on dialysis. If you are listed for a KDPI >85% Donor kidney, you may still get a Standard-Criteria Donor kidney if one becomes available. You may remove yourself from the list for a KDPI >85% Donor kidney at any time and at no penalty. You have the right to refuse this KDPI >85% Donor kidney when it is offered. This refusal will not impact your status on the UNOS transplant wait list for standard-criteria kidneys. time. I understand the benefits and risks of the KDPI >85% Donor and I agree to be on the list for this type of kidney transplant. I do not wish to be placed on the wait list for the KDPI >85% Donor kidney. HH Forms 577068 R11-14 Printed by the Digital Print Center @ HH Page 2 of 5

3. Donors after Cardiac Death These organs are from individuals that have had an irreversible and devastating neurological injury and the patient s family and physician have decided that life support will be discontinued. These patients are not brain dead by neurological criteria but will be pronounced dead once the patient s heart stops. Once this happens the patient can donate organs, which include lungs, liver, pancreas and kidneys. Kidneys from Donors after Cardiac Death work almost as well as Standard-Criteria Donor kidneys. However, there is a higher risk of delayed kidney function with Donors after Cardiac Death kidneys, which may require the recipient to receive dialysis for a period of time after transplant. This risk may also increase the overall risks of the transplant surgery itself and the risks and side effects of the post-transplant medications. Once full kidney function is obtained, however, Donors after Cardiac Death kidneys generally function as well as kidneys from standard-criteria donors. Most people who have Donors after Cardiac Death kidneys will live longer than those on dialysis. Studies have indicated that a transplant from a Donor after Cardiac Death may be better than no transplant at all. Patients in such studies who had kidneys from Donors after Cardiac Death lived longer than those on dialysis who never received a transplant. You will be provided a copy of the Scientific Registry of Transplant Recipients ( SRTR ) annual data report if you request it. Being listed for an Donors after Cardiac Death kidney may shorten the wait time for a transplant. Waiting times get longer every year and many patients die waiting for a kidney transplant. A reduced wait time may also increase the chance of receiving a transplant before beginning dialysis. Patients who receive a kidney transplant prior to beginning dialysis in general experience fewer complications associated with their kidney disease and transplant than those who are transplanted after being on dialysis. If you are listed for a Donors after Cardiac Death kidney you may still get a Standard-Criteria Donor kidney if one becomes available. You may remove yourself from the list for a Donors after Cardiac Death kidney at any time and at no penalty. You have the right to refuse this Donors after Cardiac Death kidney when it is offered to you. This refusal will not impact your status on the UNOS transplant wait list for standard-criteria kidneys. time. I understand the benefits and risks of the Donors after Cardiac Death kidney and I agree to be on the list for this type of kidney transplant. I do not wish to be placed on the wait list for the Donors after Cardiac Death kidney. 4. Hepatitis B Positive Donors These organs are from donors who otherwise meet the criteria for Standard-Criteria Donors but who may have had active hepatitis B or who have been exposed to hepatitis B in the past. In order for you to receive a kidney from this type of donor you must have received the hepatitis B immunizations or have become immunized from a prior hepatitis B exposure and have had a blood test to prove that you are immune to the hepatitis B virus. HH Forms 577068 R11-14 Printed by the Digital Print Center @ HH Page 3 of 5

A kidney from a hepatitis B-positive donor functions as well as a kidney from a Standard-Criteria Donor. You may receive Scientific Registry of Transplant Recipients ( SRTR ) data concerning this if you request it. However, receiving a kidney from this type of donor presents a small risk of getting the hepatitis B virus from the donor, but the risk of transmission is very low. The risk of contracting hepatitis B this way is less than the risk of death on dialysis. Hepatitis B does not affect the kidney; it is a liver infection. Patients who contract hepatitis B may experience liver failure and require a liver transplant to survive. If you agree to accept a kidney from a hepatitis B-positive donor you will need to have extra blood tests after transplant at various intervals to test for the hepatitis B virus. You may also be required to take extra medications to treat or prevent you from acquiring the hepatitis B virus. If you receive a kidney from a hepatitis B-positive donor, the Hartford Hospital Transplant Program will monitor the status of your liver after transplant by blood tests which measure liver function and hepatitis B viral loads. If you are listed for a hepatitis B-positive donor kidney you may still get a Standard-Criteria Donor kidney if one becomes available. time. I understand the benefits and risks of the hepatitis B positive kidney and I agree to be on the list for this type of kidney transplant. I do not wish to be placed on the wait list for the hepatitis B positive kidney. You may remove yourself from the list for a hepatitis B-positive donor kidney at any time and at no penalty. You have the right to refuse a hepatitis B positive donor kidney when it is offered to you. This refusal will not impact your status on the UNOS transplant wait list for a standard-criteria kidney 5. Donors who are at higher risk for disease transmission I have been given the information regarding the donors who are at higher risk for disease transmission as identified by the Public Health Service 2013. HH Forms 577068 R11-14 Printed by the Digital Print Center @ HH Page 4 of 5

I affirm that I understand the risks and benefits associated with organs from each type of donor described above, and that I have indicated my wishes as to the types of donor organs I am willing to consider accepting if offered to me. I understand that I may refuse any organ when offered without affecting my status on the UNOS transplant wait list. Additionally, if I indicated a willingness to accept an organ from an Extended Criteria Donor, a Donor after Cardiac Death and/or hepatitis B positive donor, I understand that I may remove myself from any or all of these lists at any time without affecting my status on the UNOS transplant wait list for standard-criteria kidneys. Signed: (Patient or legally authorized representative) Signature (MD, APRN, PA, RN) Interpreter responsible for explaining procedures and special treatment: (Interpreter) PATIENT UNABLE TO SIGN [ ] BECAUSE: M.D., PA, APRN Witness HH Forms 577068 R11-14 Printed by the Digital Print Center @ HH Page 5 of 5